{
  "note_id": "gold_t2dm_004",
  "scenario": "t2dm",
  "persona": "gold",
  "note_text": "**Clinical Note**\n\n**Patient Name:** Michael Brown  \n**Age:** 47 years  \n**Gender:** Male  \n**Occupation:** High school teacher  \n**BMI:** 32.4  \n\n**Chief Complaint:**  \n\"Diabetes follow-up\"\n\n**History of Present Illness:**  \nMichael Brown is a 47-year-old male with a 3-year history of Type 2 Diabetes Mellitus presenting for routine management. His diabetes is currently very poorly controlled, with a recent HbA1c of 10.2%. He reports fasting glucose readings between 160-220 mg/dL and postprandial readings between 180-250 mg/dL. He is adherent to Metformin 1000mg twice daily, though he occasionally experiences gastrointestinal upset. No episodes of hypoglycemia have been reported. He notes occasional tingling in his feet and concerns about a potential foot ulcer, though no visual changes or weight loss. He also reports erectile dysfunction, which may be related to his diabetes. He has a sedentary lifestyle, struggles with portion control, and consumes soda daily. His last eye exam was 8 months ago, showing no retinopathy.\n\n**Review of Systems:**  \n- **General:** No fatigue, no weight loss.  \n- **Endocrine:** No polyuria, no polydipsia.  \n- **Neurological:** Reports tingling in feet occasionally.  \n- **Ophthalmologic:** No visual changes.  \n- **Gastrointestinal:** Occasional GI upset with Metformin.  \n- **Genitourinary:** Occasional erectile dysfunction.  \n- **Integumentary:** Concern for potential foot ulcer, no current wounds reported.  \n\n**Past Medical History:**  \n- Type 2 Diabetes Mellitus  \n- Hypertension  \n- Hyperlipidemia  \n\n**Medications:**  \n- Metformin 1000mg twice daily  \n- Lisinopril 20mg daily  \n- Atorvastatin 20mg daily  \n\n**Allergies:**  \nNo known drug allergies.\n\n**Social History:**  \n- Occupation: High school teacher, sedentary job.  \n- Lifestyle: Minimal exercise, struggles with portion control, daily soda consumption.  \n\n**Physical Examination:**  \n- **Vital Signs:** BP 128/78 mmHg, HR 78, Weight 185 lbs, BMI 32.4, Temperature 98.6\u00b0F  \n- **General:** Alert, obese, pleasant demeanor.  \n- **Cardiovascular:** Regular rate and rhythm, no murmurs, peripheral pulses 2+ dorsalis pedis and posterior tibial bilaterally.  \n- **Respiratory:** Clear to auscultation bilaterally.  \n- **Extremities:** Monofilament test shows protective sensation intact bilaterally, skin intact, no open wounds or calluses, no edema, pedal pulses palpable.  \n- **Feet:** No visible deformities, nails trimmed, no fungal infection. Concern noted for potential ulcer, but no obvious signs currently.\n\n**Assessment and Plan:**  \n1. **Type 2 Diabetes Mellitus, uncontrolled (ICD-10: E11.65):**  \n   - Add Semaglutide 0.25mg subcutaneous weekly, increase to 0.5mg after 4 weeks.  \n   - Continue Metformin 1000mg twice daily.  \n   - Order HbA1c in 3 months.  \n   - Referral to diabetes educator for nutrition counseling.  \n   - Patient education on glucose targets and Semaglutide injection.\n\n2. **Obesity (ICD-10: E66.9):**  \n   - Lifestyle counseling: Eliminate sugar-sweetened beverages, use smaller plates for portion control, increase physical activity to 150 min/week.  \n   - Weight loss goal: 5-10% body weight (9-18 lbs) over 6 months.  \n\n3. **Essential hypertension, controlled (ICD-10: I10):**  \n   - Continue Lisinopril 20mg daily.  \n\n4. **Hyperlipidemia (ICD-10: E78.5):**  \n   - Continue Atorvastatin 20mg daily.  \n\n5. **Diabetic foot care:**  \n   - Evaluate foot for potential ulcer, educate on proper foot care.  \n\n6. **Sexual dysfunction:**  \n   - Discussed potential link with diabetes and vascular health; consider PDE5 inhibitors if persistent.  \n\n7. **Preventive care:**  \n   - Ensure flu vaccine, check pneumococcal status.  \n   - Referral to ophthalmology for annual dilated eye exam.  \n   - Order annual kidney function tests (BMP, urinalysis with microalbumin).  \n\n**Time Spent:**  \n25 minutes with extensive medication counseling and lifestyle education.\n\n**Billing Level:**  \n99214 (Established patient, moderate to high complexity due to uncontrolled chronic disease)\n\n**Medical Decision Making:**  \nDocumented assessment of glycemic control with HbA1c at 10.2%, indicating very poor control despite Metformin. Cardiovascular risk elevated due to diabetes, obesity, and age. Decision to add GLP-1 agonist for glucose control and weight loss, with additional cardiovascular benefits. Discussed injection technique and expected side effects. Addressed lifestyle change barriers due to work schedule and dietary habits. Screening for complications current except ophthalmology (referral placed).",
  "demographics": {
    "age": 47,
    "gender": "M",
    "occupation": "high school teacher",
    "name": "Michael Brown"
  },
  "generated_at": "2026-02-14T01:54:56.415452",
  "ground_truth_scores": {
    "completeness": 90,
    "accuracy": 95,
    "compliance": 85,
    "risk": 92,
    "clarity": 93
  }
}